According to BioNexus Gene Lab's latest financial reports the company has $5.92 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $2.11 M | -0.24% |
2021-12-31 | $2.12 M | -23.81% |
2020-12-31 | $2.78 M | 224.5% |
2019-12-31 | $0.85 M | -31.83% |
2018-12-31 | $1.26 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.20 B | 3,411.13% | ๐บ๐ธ USA |